Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Cerilliant
McKinsey
Medtronic
Deloitte
Johnson and Johnson
US Army
Chubb
Federal Trade Commission

Generated: February 21, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: RUXOLITINIB PHOSPHATE

« Back to Dashboard

RUXOLITINIB PHOSPHATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Incyte Corp JAKAFI ruxolitinib phosphate TABLET;ORAL 202192 NDA Incyte Corporation 50881-005-60 60 TABLET in 1 BOTTLE, PLASTIC (50881-005-60)
Incyte Corp JAKAFI ruxolitinib phosphate TABLET;ORAL 202192 NDA Incyte Corporation 50881-010-01 28 TABLET in 1 BOTTLE, PLASTIC (50881-010-01)
Incyte Corp JAKAFI ruxolitinib phosphate TABLET;ORAL 202192 NDA Incyte Corporation 50881-010-60 60 TABLET in 1 BOTTLE, PLASTIC (50881-010-60)
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Chubb
Teva
Medtronic
Cerilliant
Mallinckrodt
Argus Health
Julphar
Deloitte